CORD-19:775b90287b44353bee979abb0970a4666022f86d / 630094-630294 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/775b90287b44353bee979abb0970a4666022f86d","sourcedb":"CORD-19","sourceid":"775b90287b44353bee979abb0970a4666022f86d","text":"Thirteen patients ≥16 years developed nonneutralizing anti-rHuPH20 antibody titers ≥1:160 on 1 or more occasion with no associated AEs; titers declined despite continuing rHuPH20 in 12 of 13 patients.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T99783","span":{"begin":0,"end":200},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T99783","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T421","span":{"begin":0,"end":200},"obj":"Sentence"}],"attributes":[{"subj":"T421","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93b1ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#cbec93"}]}]}}